mhGAP Intervention Guide for Mental, Neurological and Substance-use Disorders in Non-specialized Health Settings - Version 2.0

Mental health Gap Action Programme (mhGAP)

January 2017
More details
  • Publisher
    World Health Organization
  • Published
    27th January 2017
  • ISBN 9789241549790
  • Language English
  • Pages 170 pp.
  • Size 8.25" x 11.75"

The mhGAP Intervention Guide (mhGAP-IG) for Mental, Neurological and Substance-use Disorders for Non-specialist Health Settings is a technical tool developed by WHO to assist in implementation of mhGAP. The Intervention Guide has been developed through a systematic review of evidence followed by an international consultative and participatory process.

The mhGAP-IG presents integrated management of priority conditions using protocols for clinical decision-making. The priority conditions included are: depression, psychosis, bipolar disorders, epilepsy, developmental and behavioral disorders in children and adolescents, dementia, alcohol use disorders, drug use disorders, self-harm/suicide, and other significant emotional or medically unexplained complaints.

The mhGAP-IG is a model guide and has been developed for use by health-care providers working in non-specialized health-care settings after adaptation for national and local needs.

World Health Organization

World Health Organization is a Specialized Agency of the United Nations, charged to act as the world's directing and coordinating authority on questions of human health. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends.